Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multi-center Phase Ib/II Study of MK-1045 (CN201) in Subjects With Precursor B-cell Acute Lymphoblastic Leukemia

NCT05579132 is registered in ClinicalTrials.gov with MSD R&D (China) Co., Ltd. as lead sponsor.

NCT NCT05579132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05579132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multi-center Phase Ib/II Study of MK-1045 (CN201) in Subjects With Precursor B-cell Acute Lymphoblastic Leukemia
Lead sponsor
MSD R&D (China) Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 1, 2022
Completion date
December 31, 2028
Enrollment
203 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia